Non‐Fullerene Acceptors Assisted Target Therapy for Interface Treatment Enable High Performance Inverted Perovskite Solar Cells
Small · 2024-07 · 20 (28)
DOI: 10.1002/smll.202310742 ↗Kurz gefasst
Fachartikel in der Zeitschrift Small, online erschienen am 08.02.2024. Verfasst von Zhenwei Pu und 9 weiteren Autor:innen. Beteiligte Einrichtung: Zhejiang Provincial Engineering Research Center of Energy Optoelectronic Materials and Devices, Ningbo Institute of Materials Technology and Engineer…. Die Arbeit wurde bisher 14-mal zitiert (Crossref) und nennt 47 Literaturangaben. Gefördert von: National Science Fund for Distinguished Young Scholars, National Natural Science Foundation of China, China Postdoctoral Science Foundation.
Abstract (Originalsprache)
Targeted treatment of the interface between electron transport layers (ETL) and perovskite layers is highly desirable for achieving passivating effects and suppressing carrier nonradiative recombination, leading to high performance and long‐term stability in perovskite solar cells (PSCs). In this study, a series of non‐fullerene acceptors (NFAs, Y‐H, Y‐F, and Y‐Cl) are introduced to optimize the properties of the perovskite/ETL interface. This optimization involves passivating Pb 2+ defects, releasing stress, and modulating carrier dynamics through interactions with the perovskite. Remarkably, after modifying with NFAs, the absorption range of perovskite films into the near‐infrared region is extended. As expected, Y‐F, with the largest electrostatic potential, facilitates the strongest interaction between the perovskite and its functional groups. Consequently, champion power conversion efficiencies of 21.17%, 22.21%, 23.25%, and 22.31% are achieved for control, Y‐H‐, Y‐F‐, and Y‐Cl‐based FA 0.88 Cs 0.12 PbI 2.64 Br 0.36 (FACs) devices, respectively. This treatment also enhances the heat stability and air stability of the corresponding devices. Additionally, these modifier layers are applied to enhance the efficiency of Cs 0.05 (FA 0.95 MA 0.05 ) 0.95 PbI 2.64 Br 0.36 (FAMA) devices. Notably, a champion PCE exceeding 24% is achieved in the Y‐F‐based FAMA device. Therefore, this study provides a facile and effective approach to target the interface, thereby improving the efficiency and stability of PSCs.
Schlagwörter
Stichwörter der Autor:innen
Autor:innen und Institutionen
- Zhejiang Provincial Engineering Research Center of Energy Optoelectronic Materials and Devices, Ningbo Institute of Materials Technology and Engineering, Chinese Academy of Sciences, Ningbo, 315201, P. R. China.
- Center of Materials Science and Optoelectronics Engineering, University of Chinese Academy of Sciences, Beijing, 100049, P. R. China.
ORCID-Profile: Ziyi Ge
Förderung
- National Science Fund for Distinguished Young Scholars
- National Natural Science Foundation of China
- China Postdoctoral Science Foundation
Zitieren
APA
Pu, Z., Li, J., Xie, L., Tong, X., Yang, S., Liu, J., Chen, J., Yang, M., Yang, D., & Ge, Z. (2024). Non‐Fullerene Acceptors Assisted Target Therapy for Interface Treatment Enable High Performance Inverted Perovskite Solar Cells. Small, 20(28). https://doi.org/10.1002/smll.202310742
Vancouver
Pu Z, Li J, Xie L, Tong X, Yang S, Liu J, et al. Non‐Fullerene Acceptors Assisted Target Therapy for Interface Treatment Enable High Performance Inverted Perovskite Solar Cells. Small. 2024;20(28). doi:10.1002/smll.202310742
BibTeX
@article{Pu2024,
author = {Pu, Zhenwei and Li, Jun and Xie, Lisha and Tong, Xinyu and Yang, Shuncheng and Liu, Jian and Chen, Jiujiang and Yang, Mengjin and Yang, Daobin and Ge, Ziyi},
title = {Non‐Fullerene Acceptors Assisted Target Therapy for Interface Treatment Enable High Performance Inverted Perovskite Solar Cells},
journal = {Small},
year = {2024},
volume = {20},
number = {28},
doi = {10.1002/smll.202310742}
}
EUVIMED